After the win of its merits case against the FDA, Kaival Brands and Bidi Vapor are back on track.Read More
Tags :Bidi Vapor
Litigation
News This Week
PMTA
Regulation
U.S. FDA
Vapor Makers Prevail Over FDA in PMTA Denial Suit
The FDA’s refusal to review marketing plans was error and not harmless (disagreeing with Fifth and DC Circuits).Read More
The deal allows Philip Morris Products to manufacture, promote and sell the Bidi Stick outside of the U.S.Read More
Bidi Vapor expects to enter approximately 3,900 new store locations over the next 45 days.Read More
The company expects many distribution partners to reestablish their previous sales volumes after the ruling.Read More
Partnership to offer customers who purchase Bidi Stick digital opportunities based on purchases.Read More
The company is still seeking a judicial stay pending the outcome of its lawsuit. Read More
Shares (NASDAQ: KAVL) were down 43 percent to $2.58 after the company reported Q3 earnings result.Read More
The FDA mischaracterized the Artic (Menthol) Bidi Stick as a flavored product, according to the company. Read More
The company is betting that its tobacco-derived nicotine pouch will survive regulatory scrutiny.Read More
